HUE053089T2 - Migrén kezelése acetil-leucinnal - Google Patents

Migrén kezelése acetil-leucinnal

Info

Publication number
HUE053089T2
HUE053089T2 HUE18749124A HUE18749124A HUE053089T2 HU E053089 T2 HUE053089 T2 HU E053089T2 HU E18749124 A HUE18749124 A HU E18749124A HU E18749124 A HUE18749124 A HU E18749124A HU E053089 T2 HUE053089 T2 HU E053089T2
Authority
HU
Hungary
Prior art keywords
migraine
treatment
acetyl leucine
leucine
acetyl
Prior art date
Application number
HUE18749124A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael Strupp
Mallory Factor
Original Assignee
Intrabio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59358204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE053089(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intrabio Ltd filed Critical Intrabio Ltd
Publication of HUE053089T2 publication Critical patent/HUE053089T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE18749124A 2017-06-14 2018-06-25 Migrén kezelése acetil-leucinnal HUE053089T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1709459.0A GB201709459D0 (en) 2017-06-14 2017-06-14 Treatment for migraine
EP18749124.6A EP3638370B1 (en) 2017-06-14 2018-06-25 Treatment of migraine with acetyl-leucine

Publications (1)

Publication Number Publication Date
HUE053089T2 true HUE053089T2 (hu) 2021-06-28

Family

ID=59358204

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18749124A HUE053089T2 (hu) 2017-06-14 2018-06-25 Migrén kezelése acetil-leucinnal

Country Status (25)

Country Link
US (1) US11471434B2 (enExample)
EP (1) EP3638370B1 (enExample)
JP (1) JP7130739B2 (enExample)
KR (1) KR102594130B1 (enExample)
CN (1) CN111093772B (enExample)
AU (1) AU2018284330B2 (enExample)
CY (1) CY1123860T1 (enExample)
DK (1) DK3638370T3 (enExample)
ES (1) ES2847169T3 (enExample)
GB (1) GB201709459D0 (enExample)
HR (1) HRP20210108T1 (enExample)
HU (1) HUE053089T2 (enExample)
IL (1) IL271211B2 (enExample)
LT (1) LT3638370T (enExample)
MA (1) MA49396B1 (enExample)
MD (1) MD3638370T2 (enExample)
MX (1) MX387909B (enExample)
PL (1) PL3638370T3 (enExample)
PT (1) PT3638370T (enExample)
RS (1) RS61481B1 (enExample)
SG (1) SG11201912146RA (enExample)
SI (1) SI3638370T1 (enExample)
SM (1) SMT202100037T1 (enExample)
WO (1) WO2018229738A1 (enExample)
ZA (1) ZA201908087B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019221886B2 (en) * 2018-02-15 2024-08-08 Intrabio Ltd Therapeutic agents for treating restless legs syndrome
JP7471298B2 (ja) 2018-12-06 2024-04-19 イントラビオ エルティーディー アセチル－ロイシンの重水素化類似体

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701662L (sv) * 1987-04-22 1988-10-23 Gelder Nico M Van Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
US20060063827A1 (en) 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
MY142655A (en) * 2003-06-12 2010-12-15 Euro Celtique Sa Therapeutic agents useful for treating pain
EP1641775B1 (en) * 2003-07-03 2009-02-18 Euro-Celtique S.A. 2-pyridine alkyne derivatives useful for treating pain
CN1856484B (zh) * 2003-07-24 2010-09-22 欧洲凯尔蒂克公司 用于治疗或预防疼痛的杂芳基-四氢吡啶基化合物
JP4634385B2 (ja) * 2003-09-22 2011-02-16 ユーロ−セルティーク エス．エイ． 疼痛の治療に有用なフェニル−カルボキサミド化合物
DE602004017481D1 (de) * 2003-09-22 2008-12-11 Euro Celtique Sa Zur behandlung von schmerzen geeignete therapeutische mittel
DE602004019576D1 (de) * 2003-12-30 2009-04-02 Euro Celtique Sa Zur behandlung von schmerzen geeignete piperazine
FR2905600B1 (fr) 2006-09-13 2010-01-15 Pf Medicament Traitement des vertiges par l'acetyl-l-leucine.
TN2010000251A1 (fr) 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
JP5876423B2 (ja) * 2010-06-22 2016-03-02 塩野義製薬株式会社 Ｔｒｐｖ１阻害活性を有する化合物とその使用
EP3103469B1 (en) 2010-06-25 2020-12-09 Shire Human Genetic Therapies, Inc. Cns delivery of therapeutic agents
ES2732818T3 (es) * 2010-11-09 2019-11-26 Mannkind Corp Composición que comprende un agonista de receptores de serotonina y una dicetopiperazina para tratar migrañas
WO2013021276A1 (en) * 2011-08-10 2013-02-14 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
KR102791288B1 (ko) 2016-04-19 2025-04-03 인트라바이오 리미티드 이동성 및 인지 기능을 개선시키기 위한 아세틸-류신 또는 이의 약제학적으로 허용되는 염
MA43876B1 (fr) 2016-08-11 2019-04-30 Intrabio Ltd Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale
AU2017308865B2 (en) 2016-08-11 2023-04-13 Intrabio Limited Therapeutic agents for neurodegenerative diseases
LT3600276T (lt) 2017-03-28 2023-08-10 Intrabio Ltd Betahistinas arba farmaciniu požiūriu priimtina jo druska ir monoaminooksidazės inhibitorius, skirti panaudoti subjekto gydymui arba profilaktikai vieno arba daugiau vestibulinio galvos svaigimo simptomų
RU2763425C2 (ru) 2017-10-18 2021-12-29 Интрабио Лимитед Терапевтические агенты для нейродегенеративных заболеваний
WO2019079536A1 (en) 2017-10-18 2019-04-25 Intrabio Ltd THERAPEUTIC AGENTS FOR IMPROVED MOBILITY AND COGNITIVE FUNCTION AND FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND LYSOSOMAL STORAGE DISORDERS
AU2019221886B2 (en) 2018-02-15 2024-08-08 Intrabio Ltd Therapeutic agents for treating restless legs syndrome
JP7471298B2 (ja) 2018-12-06 2024-04-19 イントラビオ エルティーディー アセチル－ロイシンの重水素化類似体
SI3934637T1 (sl) 2019-03-02 2024-10-30 Intrabio Ltd Summit House (N-)acetil-L-levcin za uporabo pri zdravljenju travmatske poškodbe možganov
PL3989962T3 (pl) 2019-06-28 2025-11-17 Intrabio Ltd Terapia skojarzona acetyloleucyną i miglustatem w leczeniu lizosomalnej choroby spichrzeniowej
US20230051742A1 (en) 2020-01-13 2023-02-16 Intrabio Ltd. Treatment of late-onset neurodegenerative diseases in heterozygous npc1 gene mutation carriers

Also Published As

Publication number Publication date
PL3638370T3 (pl) 2021-05-17
KR20210013518A (ko) 2021-02-04
SMT202100037T1 (it) 2021-03-15
ES2847169T3 (es) 2021-08-02
DK3638370T3 (da) 2021-01-25
US20200253905A1 (en) 2020-08-13
CN111093772A (zh) 2020-05-01
CN111093772B (zh) 2023-11-03
ZA201908087B (en) 2024-11-27
SI3638370T1 (sl) 2021-04-30
CY1123860T1 (el) 2022-05-27
WO2018229738A1 (en) 2018-12-20
AU2018284330B2 (en) 2024-03-14
IL271211B1 (en) 2023-09-01
MA49396B1 (fr) 2021-03-31
RU2020100475A (ru) 2021-07-14
KR102594130B1 (ko) 2023-10-24
JP7130739B2 (ja) 2022-09-05
CA3067321A1 (en) 2018-12-20
MD3638370T2 (ro) 2021-04-30
HRP20210108T1 (hr) 2021-03-19
EP3638370B1 (en) 2020-11-11
EP3638370A1 (en) 2020-04-22
JP2020526575A (ja) 2020-08-31
US11471434B2 (en) 2022-10-18
BR112019026660A2 (pt) 2020-07-14
MX387909B (es) 2025-03-19
MA49396A (fr) 2020-04-22
RU2020100475A3 (enExample) 2021-10-22
MX2019014784A (es) 2021-11-16
AU2018284330A1 (en) 2020-01-02
SG11201912146RA (en) 2020-01-30
PT3638370T (pt) 2021-01-26
RS61481B1 (sr) 2021-03-31
LT3638370T (lt) 2021-03-25
GB201709459D0 (en) 2017-07-26
IL271211B2 (en) 2024-01-01
IL271211A (en) 2020-01-30

Similar Documents

Publication Publication Date Title
EP3402517A4 (en) Immunologic treatment of cancer
EP3488001A4 (en) TREATMENT OF CANCER
IL263680A (en) Combination therapies
PL3265053T3 (pl) Sposoby leczenia skóry
PL3283527T3 (pl) Leczenie skojarzone nowotworów
PT3368534T (pt) Ditosilato de valbenazina e polimorfos do mesmo
HRP20181130T1 (hr) Postupci za liječenje infekcija virusom filoviridae
HUE056287T2 (hu) Pancreatitis kezelése
CL2016002255A1 (es) Inhibidores de c5a para el tratamiento de la neumonía viral
EP3432888A4 (en) CANCER TREATMENT WITH TG02
LT3645518T (lt) Omekamitivo mekarbilo sintezė
EP3379139A4 (en) LAMPHOLDER
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
PT3622953T (pt) Tratamento combinado do cancro
IL272851A (en) Methods of using dipivefrin
BR112016022976A2 (pt) Métodos para o tratamento de hcv
LT3307267T (lt) Išsėtinės sklerozės gydymas
EP3619170A4 (en) WATER TREATMENT PROCESS
EP3658253A4 (en) BIOPOLYMERIC WATER TREATMENT
HUE055778T2 (hu) Oligo-ovulációval összefüggõ májzsírosodás kezelése
EP3479227A4 (en) CORRELATION OF MULTIPLE SOURCES
EP3375286A4 (en) WRINKLE WASPS PROTECTION PRODUCTS
EP3277701A4 (en) SYNTHESIS OF DESOSAMINES
FR3037803B1 (fr) Implant de substitution du sternum
KR20180084983A (ko) 암의 치료를 위한 피리미도-피리미다지논의 용도